POST-NEUROSURGICAL INFECTIONS RELATED TO VENTRICULOPERITONEAL SHUNT PLACEMENT IN CHILDREN: CURRENT SITUATION AND STRATEGIES TO IMPROVE TREATMENT OUTCOMES AT THE VIETNAM NATIONAL CHILDREN’S HOSPITAL

Hữu Nam Đào, Văn Lâm Nguyễn , Vũ Hùng Cao, Thu Hương Nguyễn , Thế Hiệp Nguyễn

Main Article Content

Abstract

Background: Post-neurosurgical bacterial meningitis (PNM) is a severe complication frequently observed in patients with intracranial devices or ventricular drainage systems. In recent years, global research has increasingly focused on the causative pathogens, treatment challenges, prognosis, and therapeutic outcomes associated with this condition. Objectives: To describe the clinical and laboratory characteristics, etiological agents, and antimicrobial resistance patterns in pediatric patients with meningitis associated with ventriculoperitoneal shunt at the Vietnam National Children’s Hospital. Subjects and Methods: A combined retrospective and prospective study was conducted at the Vietnam National Children’s Hospital from January 2020 to September 2025. The study population included pediatric patients aged from 1 month to under 15 years, diagnosed with post-neurosurgical meningitis following ventriculoperitoneal shunt placement. Results: A total of 46 patients were included during the study period. The most common pathogens were Streptococcus pneumoniae (32,61%), Staphylococcus aureus (15,22%), and Escherichia coli (15,22%), with a high prevalence of multidrug resistance. The overall mortality rate was 6.5%. Conclusions: Multidrug-resistant Gram-positive bacteria are emerging as the predominant causative agents of post-neurosurgical bacterial meningitis. Their high resistance rates represent a major contributor to treatment failure and increased mortality.

Article Details

References

TunkelAR, Hasbun, Bhimraj A, et al. IDSA guidelines for healthcare-associated ventriculitis and meningitis. Clin Infec Dis. 2017;64(6):e34-e65.
2. Karvouniaris M, Frantzeskaki F, Karamouzos V, et al. Current perspectives on the diagnosis and management of ventriculitis and EVD-associated infections. Infect Drug Resist. 2022;15:5737-5750.
3. Choo YH, et al. Significant reduction in external ventricular drain-related infections after implementation of a bundle: a single-center study. J Neurosurg.2023;139(1):88-96.
4. Gutierrez-Murgas Y, Snowden JN. Ventricular shunt infections: immunopathogenesis and biofilm implications. Pathogens. 2014;3(2):370–386.
5. Robinson JL, Lee BE, Patel J, et al. Treatment strategies for cerebrospinal shunt infections: a systematic review of the literature. BMJ Open. 2020;10(9):e037272.
6. Dorresteijn K, Dammers R, van de Beek D, et al. Factors and measures predicting external cerebrospinal fluid drain-associated infection: a systematic review and meta-analysis. Neurology. 2019;93(24):e2211–e2222.
7. Asif AA, Khan M, Ahmed S, et al. Bacterial ventriculoperitoneal shunt infections: microbiology and antimicrobial susceptibility patterns in adults. Cureus. 2023;15(3):e35427.
8. Paff M, Alexandru-Abrams D, Muhonen M, Loudon W. Ventriculoperitoneal shunt complications: a review. Neurosurg Rev. 2018; 41(4):919–931.
9. Diallo M, Benmohamed H, Nguyen AT, et al. Incidence of infection after shunt implantation using antibiotic-impregnated catheters: a multicenter prospective study. Childs Nerv Syst. 2024;40(5):1023–1031.
10. World Health Organization. Surgical site infection: global data and prevention [Internet]. Geneva: WHO; 2023 [cited 2025 Oct 18]. Available from: https://www.who.int/teams/ integrated-health-services/infection-prevention-control/surgical-site-infection